Top Markets
Coin of the day
Jafron Biomedical Co.,Ltd. Jafron Biomedical Co.,Ltd.

Jafron Biomedical Co.,Ltd.

300529
Rang in Aktien #6760
Jafron Biomedical Co.,Ltd. engages in the research and development, production,... Jafron Biomedical Co.,Ltd. engages in the research and development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.
Aktienkurs
$2.37
Marktkapitalisierung
$1.90B
Veränderung (1 Tag)
0.31%
Veränderung (1 Jahr)
-28.59%
Land
CN
Handel Jafron Biomedical Co.,Ltd. (300529)

Kategorie

Dividendenrendite-Verlauf für Jafron Biomedical Co.,Ltd. (300529)
Dividendenrendite (TTM) von Jafron Biomedical Co.,Ltd. (Aktienkürzel: 300529) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Jafron Biomedical Co.,Ltd. (300529) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber